Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Morens DM, Fauci AS. Emerging pandemic diseases: how we got to COVID-19. Cell. 2020;182(5):1077–1092. doi:10.1016/j.cell.2020.08.021
   PubMed Web of Science ®Google Scholar
• Escalera A, Gonzalez-Reiche AS, Aslam S, et al. Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission. Cell Host Microbe. 2022;30(3):373–387 e7. doi:10.1016/j.chom.2022.01.006
   PubMed Web of Science ®Google Scholar
• Krammer F. The human antibody response to influenza A virus infection and vaccination. Nat Rev Immunol. 2019;19(6):383–397. doi:10.1038/s41577-019-0143-6
   PubMed Web of Science ®Google Scholar
• Krammer F, Smith GJD, Fouchier RAM, et al. Influenza. Nat Rev Dis Primers. 2018;4(1):3. doi:10.1038/s41572-018-0002-y
   PubMed Web of Science ®Google Scholar
• Yap C, Ali A, Prabhakar A, et al. Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic. Ther Adv Vaccines Immunother. 2021;9:25151355211059791.
   Google Scholar
• Krammer F. The role of vaccines in the COVID-19 pandemic: what have we learned? Semin Immunopathol. 2023 Jul 12.
   PubMed Web of Science ®Google Scholar
• Kubale JT, Frutos AM, Balmaseda A, et al. High co-circulation of influenza and severe acute respiratory syndrome coronavirus 2. Open Forum Infect Dis. 2022;9(12):ofac642. doi:10.1093/ofid/ofac642
   PubMed Web of Science ®Google Scholar
• Rao S, Armistead I, Tyler A, et al. Respiratory syncytial virus, influenza, and coronavirus disease 2019 hospitalizations in children in Colorado during the 2021–2022 respiratory virus season. J Pediatr. 2023;260:113491. doi:10.1016/j.jpeds.2023.113491
   PubMed Web of Science ®Google Scholar
• Aydillo T, Escalera A, Strohmeier S, et al. Pre-existing hemagglutinin stalk antibodies correlate with protection of lower respiratory symptoms in flu-infected transplant patients. Cell Rep Med. 2020;1(8):100130. doi:10.1016/j.xcrm.2020.100130
   PubMedGoogle Scholar
• Andrews N, Tessier E, Stowe J, et al. Duration of protection against mild and severe disease by COVID-19 vaccines. N Engl J Med. 2022;386(4):340–350. doi:10.1056/NEJMoa2115481
   PubMed Web of Science ®Google Scholar
• Lazarus R, Baos S, Cappel-Porter H, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021;398(10318):2277–2287. doi:10.1016/S0140-6736(21)02329-1
   PubMed Web of Science ®Google Scholar
• Hall KT, Stone VE, Ojikutu B. Reactogenicity and concomitant administration of the COVID-19 booster and influenza vaccine. JAMA Netw Open. 2022;5(7):e2222246. doi:10.1001/jamanetworkopen.2022.22246
   PubMed Web of Science ®Google Scholar
• Janssen C, Mosnier A, Gavazzi G, et al. Coadministration of seasonal influenza and COVID-19 vaccines: a systematic review of clinical studies. Hum Vaccin Immunother. 2022;18(6):2131166. doi:10.1080/21645515.2022.2131166
   PubMed Web of Science ®Google Scholar
• Wagenhauser I, Reusch J, Gabel A, et al. Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination. Eur Respir J. 2023 Jan;61(1).
   PubMed Web of Science ®Google Scholar
• Dulfer EA, Geckin B, Taks EJM, et al. Timing and sequence of vaccination against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial. Lancet Reg Health Eur. 2023;29:100628. doi:10.1016/j.lanepe.2023.100628
   PubMedGoogle Scholar
• Cordero E, Aydillo TA, Perez-Ordonez A, et al. Deficient long-term response to pandemic vaccine results in an insufficient antibody response to seasonal influenza vaccination in solid organ transplant recipients. Transplantation. 2012;93(8):847–854. doi:10.1097/TP.0b013e318247a6ef
   PubMed Web of Science ®Google Scholar
• Aydillo T, Gonzalez-Reiche AS, Stadlbauer D, et al. Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination. NPJ Vaccines. 2022;7(1):160. doi:10.1038/s41541-022-00583-w
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Hyun HJ, et al. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults. Vaccine. 2017 Jan 5;35(2):313–320.
   PubMed Web of Science ®Google Scholar
• Ofori-Anyinam O, Leroux-Roels G, Drame M, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults >/=50years of age: results from a phase III, randomized, non-inferiority trial. Vaccine. 2017;35(46):6321–6328. doi:10.1016/j.vaccine.2017.09.012
   PubMed Web of Science ®Google Scholar
• Frenck RW, Gurtman A, Rubino J, et al. Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults. Clin Vaccine Immunol. 2012;19(8):1296–1303. doi:10.1128/CVI.00176-12
   PubMed Web of Science ®Google Scholar
• Seki M. Strategies for geriatric pneumonia in healthcare facilities – How effective is combined influenza and pneumococcal vaccination? Int J Gen Med. 2020;13:663–666. doi:10.2147/IJGM.S264835
   PubMed Web of Science ®Google Scholar
• Hanafy AS, Seleem WM, Elkattawy HA. Potential impact of combined influenza and pneumococcal vaccines on the severity of respiratory illness in COVID-19 infection among type 2 diabetic patients. Clin Exp Med. 2023 Feb;23(1):141–150.
   PubMed Web of Science ®Google Scholar
• Hedlund J, Christenson B, Lundbergh P, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine. 2003;21(25-26):3906–3911. doi:10.1016/S0264-410X(03)00296-2
   PubMed Web of Science ®Google Scholar
• Haas JW, Bender FL, Ballou S, et al. Frequency of adverse events in the placebo arms of COVID-19 vaccine trials: A systematic review and meta-analysis. JAMA Netw Open. 2022;5(1):e2143955. doi:10.1001/jamanetworkopen.2021.43955
   PubMed Web of Science ®Google Scholar
• Govaert TM, Dinant GJ, Aretz K, et al. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. Br Med J. 1993;307(6910):988–990. doi:10.1136/bmj.307.6910.988
   PubMed Web of Science ®Google Scholar